Our in vitro TRAIL release studies showed that TRAIL was released at concentrations within the aforementioned range, and as such, we hypothesized that iNSC-laden CS and CS-CNC hydrogel scaffolds should suppress tumor cell growth and proliferation. This evidence concerns the gene TNFSF10 and neoplasm.